Learn more

ANTEIS SA

Overview
  • Total Patents
    118
  • GoodIP Patent Rank
    38,437
  • Filing trend
    ⇩ 33.0%
About

ANTEIS SA has a total of 118 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are VAN EPPS DENNIS E, TEOXANE and ABRAHMSOHN GLENN.

Patent filings per year

Chart showing ANTEIS SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Gavard Molliard Samuel 42
#2 Benoit Olivier 20
#3 Hermitte Laurence 18
#4 Bos Gilles 11
#5 Vinchon Cyrille 10
#6 Samuel Gavard Molliard 8
#7 Dreher Frank 7
#8 Olivier Benoit 6
#9 Gavard Samuel 5
#10 Tauzin Bénédicte Vincente 5

Latest patents

Publication Filing date Title
US2018221255A1 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use
US2019269597A1 Hyaluronic acid dermal fillers crosslinked with citric acid, method for making same and uses thereof
US2017065741A1 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use
CN105705137A Method for obtaining an injectable hydrogel based on hyaluronic acid containing lidocaine added in powder form, and an alkaline agent, sterilized with heat
SG11201510103YA Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel
WO2014198406A1 Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel
BR112015007772A2 sterile injectable aqueous formulation containing cross-linked hyaluronic acid and hydroxyapatite for aesthetic use
WO2014056723A1 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and on hydroxyapatite, for therapeutic use
CA2835773A1 Accessory for a syringe
WO2012143876A1 A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
FR2968996A1 AQUEOUS INJECTABLE STERILE FORMULATION USED IN OPHTHALMOLOGY
EP2480273A2 Assisted injection device
JP2010036032A Injectable hydrogel with enhanced remanence and with enhanced ability to create volume
FR2945949A1 Hydrogel injection for glycerol supplementation in skin over long term.
FR2938187A1 INJECTABLE COMPOSITION BASED ON HYALURONIC ACID OR ONE OF ITS HEAT-STERILIZED SALTS, POLYOLS AND LIDOCAINE
FR2918276A1 "use of a natural polysaccharide (s) gel for the preparation of an injection formulation for the treatment of joint degenerescences"
FR2909285A1 Use of an injectable or implantable antiadhesive antifibrotic gel based on a crosslinked natural or synthetic polymer for treating glaucoma or surgical wounds
FR2900575A1 BIOCOMPATIBLE CONTROLLED RELEASE GEL, PREPARATION METHOD AND USE THEREOF
FR2895907A1 VISCOELASTIC GEL FOR DERMATOLOGICAL USE
FR2874811A1 ANTIPHOTOPHOBIC OCULAR DEVICE AND METHOD FOR PREPARING THE SAME